Use of SBI in IBS Subjects Following a Successful Treatment of Small Intestinal Bacterial Overgrowth

Clinical trial NCT02251483 · COMPLETED

Trial details

NCT number: NCT02251483
Sponsor: Cedars-Sinai Medical Center
Status: COMPLETED
Phase: Not Applicable
Study type: INTERVENTIONAL

Diarrhea Predominant Irritable Bowel Syndrome Small Intestinal Bacterial Overgrowth

Start date: 2014-09-01
Primary completion: 2015-07-01
Enrollment: 2

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.